• Latest Posts
In Depth 27 Jun 2022

The biggest US biotech investments in May 2022

Stramsen Biotech to look at 11 plant-based drug candidates

Antheia gets funding to build biomanufacturing plant

Gemelli Biotech to work on gastrointestinal diseases with new $19M funding

US Toddlers and children to receive Covid-19 vaccine after emergency approval granted

Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding

ADVERTISEMENT

Sling Therapeutics emerges with $35M to tackle thyroid eye disease

ADVERTISEMENT